Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abvc Biopharma (ABVC) Enterprise Value (2016 - 2025)

Abvc Biopharma (ABVC) has disclosed Enterprise Value for 13 consecutive years, with $858634.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Enterprise Value rose 205.32% year-over-year to $858634.0, compared with a TTM value of $858634.0 through Dec 2025, up 205.32%, and an annual FY2025 reading of $858634.0, up 205.32% over the prior year.
  • Enterprise Value was $858634.0 for Q4 2025 at Abvc Biopharma, down from $2.2 million in the prior quarter.
  • Across five years, Enterprise Value topped out at $2.2 million in Q3 2025 and bottomed at -$6.6 million in Q4 2021.
  • Average Enterprise Value over 5 years is -$1.1 million, with a median of -$1.0 million recorded in 2023.
  • The sharpest move saw Enterprise Value plummeted 503.84% in 2024, then surged 311.12% in 2025.
  • Year by year, Enterprise Value stood at -$6.6 million in 2021, then skyrocketed by 79.99% to -$1.3 million in 2022, then rose by 23.5% to -$1.0 million in 2023, then rose by 19.87% to -$815299.0 in 2024, then surged by 205.32% to $858634.0 in 2025.
  • Business Quant data shows Enterprise Value for ABVC at $858634.0 in Q4 2025, $2.2 million in Q3 2025, and $2.1 million in Q2 2025.